Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2024
Subsidiary's use of non-corporate account to collect sales deposits results in warning letter
In 2024, the Hunan Bureau of the China Securities Regulatory Commission determined that Jiuzhitang subsidiary Mudanjiang Bobo used a non-corporate bank account to collect deposits for sales agency rights for Shuxuetong Injection from 2022 to 2024, and that there were related information disclosure issues, and issued a warning letter to the company and relevant personnel. This item is an administrative regulatory measure, not a criminal judgment.